A review of patisiran (ONPATTRO) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis
Uittenbogaard et al., 2000)
Standard Contraindications Apply All GLP-1 contraindications remain in effect: personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, pregnancy, and known hypersensitivity
Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment
In SURMOUNT 1, tirzepatide induced a mean BW reduction of 15.0%, 19.5% and 20.9% with 5 mg, 10 mg and 15 mg, respectively compared to 3.1% obtained with placebo at 72 weeks 34
I bring a wealth of experience from patient counseling to managing complex medication regimens